Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 4, 2010, Pages 327-335

  Mehta, Vivek K ^a   Algan, Ozer ^b   Griem, Katherine L ^c   Dickler, Adam ^d   Haile, Kenneth ^e   Wazer, David E ^f   Stevens, Randy E ^g   Chadha, Manjeet ^h   Kurtzman, Steve ⁱ   Modin, Sheela D ^j   Dowlatshahi, Kambiz ^c   Elliott, Kelly W ^k   Rusch, Thomas W ^k  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Providence Little Company of Mary Medical Center   (United States)

^e WellStar Health System   (United States)

^f BROWN UNIVERSITY   (United States)

^g White Plains Hospital Center   (United States)

^h BETH ISRAEL MEDICAL CENTER   (United States)

ⁱ Mills Peninsula Health Services   (United States)

^j Maryland Regional Cancer Care   (United States)

^k Xoft Inc   (United States)

more..

Author keywords

Accelerated partial breast irradiation; Breast cancer; Clinical trial; Electronic brachytherapy; Radiation treatment; X ray

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL;

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; AGED; ARTICLE; ATROPHY; BLISTER; BRACHYTHERAPY; BREAST CANCER; BREAST TENDERNESS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; ELECTRONIC BRACHYTHERAPY; ERYTHEMA; FATIGUE; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INFECTION; INTRADUCTAL CARCINOMA; MALE; MASTITIS; MEDICAL INSTRUMENTATION; MULTICENTER STUDY; PAIN; PATIENT SAFETY; PERFORMANCE; RADIATION DOSE; SEROMA; SKIN DISCOLORATION; SKIN INDURATION; BREAST; BREAST TUMOR; ELECTRONICS; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHASE 4 CLINICAL TRIAL; RADIATION EXPOSURE; SAFETY;

AGED; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; ELECTRONICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SAFETY;

EID: 77955425389     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181d79d9e     Document Type: Article

References (42)

1. Veronesi U, Banfi A, Del Vecchio M, et al. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer. Long-term results. Eur J Cancer Clin Oncol. 1986;22:1085-1089.
2. Blichert-Toft M, Brincker M, Andersen JA, et al. A Danish randomized trial comparing breast preserving therapy with a mastectomy in mammary carcinoma. Acta Oncol. 1988;27:671-677.
3. Van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer. EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;11:15-18.
4. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to a mastectomy in early breast cancer. Radiother Oncol. 1989;14:177-184.
5. Fisher B, Anderson F, Redmond C, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456-1461.
6. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breastconserving therapy in the treatment of stage I and II carcinoma of the breast. A randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10: 976-983.
7. Athas WF, Adams-Cameron M, Hunt WC, et al. Travel distance to radiation therapy and receipt of radiotherapy following breast conserving surgery. J Natl Cancer Inst. 2000;92:269-271.
8. Schroen AT, Brenin DR, Kelly MD. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005;23:7074-7080.
9. Pawlik TM, Buchholz TA, Kuerer HM. The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg. 2004;199:479-492.
10. Bhatnagar AK, Heron DE, Deutsch M, et al. Does breast size affect the scatter dose to the ipsilateral lung, heart, or contralateral breast in primary breast irradiation using intensity-modulated radiation therapy? Am J Clin Oncol. 2006;29:80-84.
11. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587-1591.
12. Liljegren G, Holmberg L, Adami HO, et al; Uppsala Oreboro Breast Cancer Study Group. Sector resection with or without post-operative radiotherapy for stage I breast cancer: Five year results of a randomized trial. J Natl Cancer Inst. 1994;86:717-722.
13. Clark RM, Whelan T, Levine M, et al; Ontario Clinical Oncology Group. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer: An update. J Natl Cancer Inst. 1996;88:1659-1664.
14. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the national surgical adjuvant breast project (protocol 6): Relation of local breast recurrence to multicentricity. Cancer. 1986;57:1717-1724. (Pubitemid 16111978)
15. Beitsch PD, Hodge CW, Dowlat K, et al. The surgeon's role in breast brachytherapy. Breast J. 2009;15:93-100.
16. Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital Breast Conservation Trial: An update at 8 years from inception. Clin Oncol. 1993; 5:278-283.
17. Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993-2001.
18. King TA, Bolton JS, Kuske RR, et al. Long term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg. 2000;180:299-304.
19. Cionini L, Pacini P, Marzano S, et al. Exclusive brachytherapy after conservative surgery in cancer of the breast [abstract] Lyon Chir. 1993;9:128.
20. Wazer DE, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:889-897.
21. Vicini FA, Kestin L, Chin P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205-1211.
22. Kuske RR. Breast brachytherapy. Hematol Oncol Clin North Am. 1999;13: 543-558.
23. Vicini FA, Jaffray DA, Horowitz EM, et al. Implementation of 3D-virtual brachytherapy in the management of breast cancer: A description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40: 629-635.
24. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS: A new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002;52:1132-1139.
25. Dickler A, Kirk MC, Seif N, et al. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007;6:164-168.
26. Rivard MJ, Davis SD, DeWerd LA, et al. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray source: An electronic brachytherapy. Med Phys. 2006;33:4020-4032.
27. Trotti A, Colevas AD, Setser A, et al. CTCAE V3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176-181.
28. Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg. 1989;124:153-157.
29. Chen SS, Strauss JB, Shah AP, et al. Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy. 2009;8:331-334.
30. Fowler JF, Dale RG, Rusch TW. Variation of RBE with dose and dose rate for a miniature electronic brachytherapy source. Med Phys. 2004;31:1927.
31. Scalliet P, Wambersie A. Which RBE for iodine 125 in clinical applications? Radiother Oncol. 1987;9:221-230.
32. Arthur DW, Vicini FA, Kuske RR, et al. Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society. Brachytherapy. 2003;2:124-130.
33. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289-293.
34. Haley M, Beriwal S, Heron DE, et al. MammoSite accelerated partial breast irradiation: A single institution outcomes analysis with two-year follow-up. Brachytherapy. 2009;8:9-13.
35. Chao KK, Vicini FA, Wallace M, et al. Analysis Of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: The William Beaumont hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32-40.
36. Richards GM, Berson AM, Resigno J, et al. Acute toxicity of high dose rate brachytherapy with the MammoSite applicator in patients with early stage breast cancer. Ann Surg Oncol. 2004;11:739-746.
37. Harper JL, Jenrette JM, Vanek KN, et al. Acute complications of MammoSite brachytherapy: A single institutions initial clinical experience. Int J Radiat Oncol Biol Phys. 2005;61:169-174.
38. Benitez PR, Keisch ME, Vicini F. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456-462.
39. Khan AJ, Kirk MC, Mehta PS, et al. A dosimetric comparison of three dimensional conformal, intensity modulated radiation therapy, and MammoSite partial breast irradiation. Brachytherapy. 2006;5:183-188.
40. Weed DW, Edmundson GK, Vicini FA, et al. Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy. 2005;4:121-129.
41. Wazer DE, Kaufman S, Cuttino L, et al. Accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:498-1495
42. Dickler A, Seif N, Kirk MC, et al. A dosimetric comparison of MammoSite and ClearPath high dose rate breast brachytherapy devices. Brachytherapy. 2009;8:1418.